Why Many Companies Are Reconsidering Coverage for GLP-1 Drugs
As GLP-1 use has exploded in the U.S., many companies have started discontinuing coverage of these treatments in the health plans they maintain for their employees. This is a trend worth watching, and it warrants a deeper look to understand why it is happening. First off, GLP-1 drugs are medicines like Wegovy and Zepbound that were designed to help in the treatment of type 2 diabetes. Many of these drugs were eventually also approved by the U.S. FDA for use in weight loss, and their use exploded. You would imagine that if these medications are being used by more and…
